COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS

BACKGROUND: The contemporaneous presence of immune defects and heart diseases in patients with 22q11.2 deletion syndrome (22q11.3DS) might represent risk factors for severe coronavirus 2019 disease (COVID-19). OBJECTIVE: To analyze severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulvirenti, Federica, Mortari, Eva Piano, Putotto, Carolina, Terreri, Sara, Fernandez Salinas, Ane, Cinicola, Bianca Laura, Cimini, Eleonora, Di Napoli, Giulia, Sculco, Eleonora, Milito, Cinzia, Versacci, Paolo, Agrati, Chiara, Marino, Bruno, Carsetti, Rita, Quinti, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584833/
https://www.ncbi.nlm.nih.gov/pubmed/36280136
http://dx.doi.org/10.1016/j.jaip.2022.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584833/
https://www.ncbi.nlm.nih.gov/pubmed/36280136
http://dx.doi.org/10.1016/j.jaip.2022.10.010

Ejemplares similares